Cases 11 - 20 of 73
Novo Nordisk Inc. et al v. Aurobindo Pharma USA, Inc. et al
as 1:2022cv00295
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. and Eugia Pharma Specialties Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Ferring Pharmaceuticals Inc. et al v. Eugia Pharma Specialties Ltd. et al
as 1:2022cv00017
Plaintiff:
Ferring Pharmaceuticals Inc., Ferring International Center S.A., Ferring B.V. and others
Defendant:
Eugia Pharma Specialties Ltd., Aurobindo Pharma Ltd. and AuroMedics Pharma LLC
Cause Of Action: 35 U.S.C. § 271
Gilead Sciences, Inc. v. Aurobindo Pharma Ltd. et al
as 1:2021cv01735
Plaintiff:
Gilead Sciences, Inc.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Azurity Pharmaceuticals, Inc. v. Aurobindo Pharma Ltd. et al
as 1:2021cv01707
Plaintiff:
Azurity Pharmaceuticals, Inc.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
BIAL - PORTELA & CA S.A., BIAL - HOLDING, S.A. et al v. Aurobindo Pharma Ltd. et al
as 1:2021cv01682
Plaintiff:
BIAL - PORTELA & CA S.A., BIAL - HOLDING, S.A. and Sunovion Pharmaceuticals Inc.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Healthcare LLC et al v. Aurobindo Pharma Ltd. et al
as 1:2021cv01575
Plaintiff:
Bayer Healthcare LLC and Meda Pharmaceuticals Inc.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 1
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Aurobindo Pharma Ltd. et al.
as 1:2021cv01485
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Aurobindo Pharma USA Inc. et al
as 1:2021cv01407
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Aurobindo Pharma USA Inc. and Aurobindo Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2021cv01330
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alkem Laboratories Ltd., Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271
Allergan USA, Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2021cv01062
Plaintiff:
Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
